2025 Global Adult And Pediatric Vaccines Market Revenue Opportunities Report
Description
The 2025 Global Adult And Pediatric Vaccines Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Adult and Pediatric Vaccines Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the adult and pediatric vaccines market globally are Pfizer, Merck & Co., GlaxoSmithKline (GSK), and Sanofi. Pfizer, headquartered in the United States, rose to prominence with its mRNA COVID-19 vaccine Comirnaty, which has also been approved for infants, in addition to vaccines for pneumonia and meningitis acquired from GSK. Merck & Co. leads with a strong vaccine portfolio including HPV, rotavirus, and shingles vaccines, generating significant revenue from vaccines like Gardasil despite a focus on oncology as well. GSK, based in the UK, specializes in vaccines for influenza, hepatitis, meningitis, and pediatric immunizations, with innovative products like the shingles vaccine Shingrix. Sanofi, headquartered in France, is a major provider of flu vaccines and childhood immunization vaccines, including polio and meningitis, through its Sanofi Pasteur division.
These companies contribute extensively to global immunization efforts, supported by large-scale research and development initiatives. Pfizer’s collaboration with BioNTech and acquisitions have expanded its vaccine portfolio significantly. Merck maintains leadership in research-driven vaccine development and broad immunization programs worldwide. GSK benefits from substantial philanthropic funding, such as from the Bill & Melinda Gates Foundation, to advance vaccines against major infectious diseases like tuberculosis. Sanofi continues to develop vaccines targeting both adult and pediatric diseases, with approvals in multiple regions, including work on COVID-19 vaccines with regulatory submissions in the US. Together, they shape worldwide vaccination strategies across age groups, leveraging innovation and extensive manufacturing and distribution networks.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Adult and Pediatric Vaccines Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the adult and pediatric vaccines market globally are Pfizer, Merck & Co., GlaxoSmithKline (GSK), and Sanofi. Pfizer, headquartered in the United States, rose to prominence with its mRNA COVID-19 vaccine Comirnaty, which has also been approved for infants, in addition to vaccines for pneumonia and meningitis acquired from GSK. Merck & Co. leads with a strong vaccine portfolio including HPV, rotavirus, and shingles vaccines, generating significant revenue from vaccines like Gardasil despite a focus on oncology as well. GSK, based in the UK, specializes in vaccines for influenza, hepatitis, meningitis, and pediatric immunizations, with innovative products like the shingles vaccine Shingrix. Sanofi, headquartered in France, is a major provider of flu vaccines and childhood immunization vaccines, including polio and meningitis, through its Sanofi Pasteur division.
These companies contribute extensively to global immunization efforts, supported by large-scale research and development initiatives. Pfizer’s collaboration with BioNTech and acquisitions have expanded its vaccine portfolio significantly. Merck maintains leadership in research-driven vaccine development and broad immunization programs worldwide. GSK benefits from substantial philanthropic funding, such as from the Bill & Melinda Gates Foundation, to advance vaccines against major infectious diseases like tuberculosis. Sanofi continues to develop vaccines targeting both adult and pediatric diseases, with approvals in multiple regions, including work on COVID-19 vaccines with regulatory submissions in the US. Together, they shape worldwide vaccination strategies across age groups, leveraging innovation and extensive manufacturing and distribution networks.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
